- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 10-11-2025: Press Release
10-11-2025 | 03:30 pm
10-11-2025 | 03:30 pm
Glenmark's subsidiary secured China approval for RYALTRIS®, a key nasal spray for Allergic Rhinitis. This major market entry boosts its respiratory portfolio globally, with Grand Pharmaceuticals managing China commercialization.
No comments yet. Be the first to comment!